
PBM reform is here.
ClearScript remains committed to transparency. For plan sponsors, recent federal reforms mean PBM decisions should be easier to understand and…


ClearScript remains committed to transparency. For plan sponsors, recent federal reforms mean PBM decisions should be easier to understand and…

Foundayo is approved for use in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults…

As pharmacy costs continue to rise, employers and their broker partners are under increasing pressure to navigate complexity, manage uncertainty,…

Manufacturer Novo Nordisk received FDA approval for oral semiglutide on 12/22/2025. These new indications for Wegovy tablets are for chronic weight management and to reduce the risk of major cardiovascular events in adults with obesity or overweight.

At ClearScript, we are committed to keeping you informed and prepared for the evolving landscape of Pharmacy Benefit Management (PBM). This update highlights key regulatory changes, industry updates, and ClearScript’s proactive strategies.

If you’re managing pharmacy benefits in 2026, you’re likely facing rising costs, new therapies, and tough decisions. So how do you stay ahead? It starts with understanding what drives trend and how to manage it with confidence.

How ClearScript Partners With You to Improve Plan Performance, Not Just Measure It. At ClearScript, we’re proud to serve as more than just your pharmacy benefit manager. We’re your partner in navigating a complex and constantly evolving pharmacy landscape. And while robust reporting is a key part of our service, it’s only the beginning.

Putting Patients First: A Collaborative Approach to Managing Rheumatoid Arthritis and Reducing Costs.

From tackling specialty drug costs to delivering member-focused solutions, Kyle breaks down what it really means to have a PBM in your corner.

A well-aligned plan isn’t just cost-effective; it’s built with purpose, supporting your broader healthcare objectives and ensuring long-term impact.

Open enrollment can be a hectic season for HR teams and a confusing time for employees. But it’s also a…

suzetrigine (VX-548) Manufacturer: Vertex Approval Date: 1/30/2025 Suzetrigine possesses a novel mechanism of action as a voltage-gated sodium channel inactivator…